CE Approval
Colin Kerr
Published: Thursday, October 1, 2020
SCHWIND eye-tech-solutions has received CE approval for the SCHWIND ATOS femtosecond laser. According to Schwind this enables refractive surgeons to offer their patients SmartSight, the latest generation of lenticular extraction developed by SCHWIND, as a treatment option.
The refractive correction is performed entirely with SCHWIND ATOS. Featuring intelligent eye tracking with pupil recognition and cyclotorsion compensation, the laser system provides precise centring of the patient’s eye along the visual axis. This ensures maximum safety and predictable treatment outcomes.
SmartSight is suitable for the treatment of myopia and astigmatism up to five dioptres. In addition, SCHWIND ATOS offers high-precision flaps for FemtoLASIK. “With the CE approval for our femtosecond laser, we have reached another milestone,” said managing director Rolf Schwind.
www.eye-tech-solutions.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.